Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2026-04-16
Summary
The overall aims of the present project are to investigate the impact of a nutritional approach based on omega-3 from vegetal origin on vascular function in hypertension associated with metabolic syndrome.
Conditions
- Essential Hypertension
- Metabolic Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
omega-3 from vegetal origin
6 months of supplementation with omega-3 from vegetal origin
- DIETARY_SUPPLEMENT
-
Placebo
6 months of supplementation with placebo
Sponsors & Collaborators
-
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Robinson Joannides, MD, PhD · University Hospital, Rouen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
Countries
- France
Study Locations
More Related Trials
-
Effect of Omega 3 in Hypertensive Patients
NCT06840964 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
NCT01699230 ·Status: UNKNOWN ·Phase: PHASE3
-
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309 ·Status: COMPLETED ·Phase: NA
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
NCT01215903 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Effect of Omega-3 Fatty Acid on Endothelial Function
NCT01813006 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With CAD
NCT02117960 ·Status: COMPLETED ·Phase: PHASE4
-
Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
NCT02178501 ·Status: COMPLETED ·Phase: NA
-
Heat Therapy and Omega 3 on Cardio-Metabolic Health
NCT04051034 ·Status: UNKNOWN ·Phase: NA
-
Omega-3 Fatty Acids and Muscle Protein Synthesis
NCT00794079 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturates and KCL to Control Mild Hypertension
NCT00000511 ·Status: COMPLETED ·Phase: PHASE2
-
SPM Regulation by Fish Oil Supplements in Healthy Volunteers
NCT03347006 ·Status: COMPLETED ·Phase: NA
-
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes
NCT02610270 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease
NCT01705678 ·Status: COMPLETED ·Phase: NA
-
Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors
NCT01343342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA
-
Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy
NCT02582710 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA